5 resultat
BRIEF SUMMARY OF THE INVENTION
The invention is novel N-[.omega.-(3-pyridinyl)alkyl]benzamides represented by the structural formula: ##STR1## wherein n is an integer from 2-5, inclusive; R is hydrogen, alkyl having from one to four carbon atoms, halogen, alkyl having from one to four carbon atoms,
BACKGROUND OF THE INVENTION
The invention relates to the prevention of ventricular fibrillation. Ventricular fibrillation can lead to sudden death, and occurs primarily in patients having myocardial infarction or other conditions which cause ischemia of cardiac tissue. The high incidence of
The invention relates to the use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events.
In particular, the invention concerns the use of polyunsaturated fatty acids of the .omega.-3 series such as eicosapentaenoic acid (EPA, C.sub.20:5 .omega.-3) docosahexaenoic
The invention relates to the use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events.
In particular, the invention concerns the use of polyunsaturated fatty acids of the .omega.-3 series such as eicosapentaenoic acid (EPA, C.sub.20:5 .omega.-3), docosahexaenoic
The invention relates to the use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events.
In particular, the invention concerns the use of polyunsaturated fatty acids of the .omega.-3 series such as eicosapentaenoic acid (EPA, C.sub.20:5 .omega.-3), docosahexaenoic